PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome
CompletedNot applicableNCT04540887
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to gather information from the investigation of a non-pharmacological (non-drug) treatment known as low frequency pulsed electromagnetic field (PEMF). The study team will be distributing the PEMF therapy to female subjects with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease pelvic pain. The results, from multiple questionnaires and voiding diaries, will be compared when participants are enrolled for treatment, at 4 weeks after using PEMF therapy, and 12 weeks post-enrollment.
Study details
- Official title
- Investigation of Potential Therapeutic Effects of Pulsed Electromagnetic Field for the Treatment of Symptoms Associated With Interstitial Cystitis/Bladder Pain Syndrome
- Conditions
- Interstitial Cystitis
- Chronic Interstitial Cystitis
- Bladder Pain Syndrome
- Interventions
- Device: Pulsed Electromagnetic Field (PEMF) Therapy
- Sponsor
- Wake Forest University Health Sciences
- Start date
- 2021-02-24
- Primary completion
- 2021-11-30
- Sex
- Female
- Age range
- from 18 Years to 80 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female patients between 18 and 80 years old * Participants must have already been diagnosed with interstitial cystitis/bladder pain syndrome * Subjects must have a bladder capacity greater than 400 cc * Participants must have scored at least a 6 or higher on Numeric Rating Scale questionnaire * Participants must not have any cognitive disabilities * Participants must not have taken any narcotic medication for at least three months before being enrolled in this clinical trial Exclusion Criteria: * Participants must not have any history of bladder, uterine, ovarian, or vaginal cancer, urethral diverticulum, spinal cord injury, stroke, Parkinson's disease, multiple sclerosis, spina bifida, radiation cystitis, cyclophosphamide treatment, or genital herpes * Patients cannot have an implanted pace-maker or metal prosthesis * Participants cannot have a urinary tract infection at the time of enrollment or be currently pregnant * Patients must not have a body mass index greater than 40
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04540887